M Mañes Sevilla

ORCID: 0000-0002-9572-0945
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Economics and Policy
  • Economic and Financial Impacts of Cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical studies and practices
  • Pharmaceutical Practices and Patient Outcomes
  • Chronic Lymphocytic Leukemia Research
  • Head and Neck Cancer Studies
  • Neutropenia and Cancer Infections
  • Oral health in cancer treatment
  • Antimicrobial Resistance in Staphylococcus
  • Systemic Sclerosis and Related Diseases
  • Health, Medicine and Society
  • Cancer Genomics and Diagnostics
  • Respiratory viral infections research
  • Quality and Safety in Healthcare
  • Multiple Myeloma Research and Treatments
  • Drug-Induced Adverse Reactions
  • Orthopedic Infections and Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Respiratory Support and Mechanisms
  • Pharmaceutical industry and healthcare
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Treatments and Studies
  • Tuberculosis Research and Epidemiology
  • Rheumatoid Arthritis Research and Therapies

Hospital Universitario de Móstoles
2015-2024

Hospital General Universitario Gregorio Marañón
2016-2018

The objectives of this study were to determine if clinical trials in breast cancer, with an investigational drug, created direct drug cost savings for the healthcare system related avoidance best standard care treatments used these studies. aim was quantify potential avoidance.We conducted a retrospective observational during period (2014-2016). We included managed by pharmacy department and provided sponsor. patients had therapeutic alternative defined as treatment that should have been...

10.1177/1078155218775193 article EN Journal of Oncology Pharmacy Practice 2018-05-23

<h3>Background and Importance</h3> Our country's legislation bans the return of dispensed drugs to Pharmacy Services, potentially leading increased costs for National Health System. <h3>Aim Objectives</h3> To estimate cost pill wastage due dose modifications discontinuation oral anticancer drugs. <h3>Material Methods</h3> Retrospective economic evaluation carried out in an intermediate complexity hospital. Using electronic medical record, dispensations between July 2022 2023 were identified....

10.1136/ejhpharm-2024-eahp.467 article EN 2024-03-01

<h3>Background and Importance</h3> Multiple myeloma (MM) is an incurable chronic disease, so the quality of life (QoL) patients with MM important criterion to consider. The patient-reported outcomes (PROs) are a fundamental tool know success treatment in clinical practice. <h3>Aim Objectives</h3> Assessing QoL as PROs adult treated daratumumab. <h3>Material Methods</h3> Retrospective observational study which included daratumumab between 01/2019 04/2023 second-level Hospital. electronic...

10.1136/ejhpharm-2024-eahp.182 article EN Section 4: Clinical pharmacy services 2024-03-01

<h3>Background and importance</h3> Tofacitinib baricitinib were recently approved for rheumatoid arthritis (RA) treatment. This was a breakthrough because of their oral administration new mechanism action. <h3>Aim objectives</h3> To analyse tofacitinib treatment RA adverse effects (AE) after starting in second level hospital. <h3>Material methods</h3> A retrospective observational study conducted all patients until September 2019. The collected variables sex, age, previous disease modifying...

10.1136/ejhpharm-2020-eahpconf.373 article EN Section 5: Patient safety and quality assurance 2020-03-01

<h3>Background</h3> The treatment of rare autoimmune diseases presents for patients the additional problem limited therapeutic options, which are usually reduced to corticosteroids and immunosuppressants. use rituximab could be an effective alternative. <h3>Purpose</h3> To determine efficacy with in diseases. <h3>Material methods</h3> Retrospective observational study who were treated between January 2008–March 2014. Data was collected from electronic prescription records. Diagnosis, reason...

10.1136/ejhpharm-2015-000639.190 article EN 2015-03-01

<h3>Background</h3> Mucositis is one of the most frequent complications in patients receiving chemotherapy. Currently there no standard treatment, and its management essentially based on adequate oral hygiene mouthwashes. In our hospital, pharmacy department compounds an suspension 250 ml sodium bicarbonate 3.5 g, gentamycin 47 mg, hydrocortisone 58 nystatin 3 000 UI mepivacaine 50 mg. <h3>Purpose</h3> The objective was to evaluate profile use mucositis compounded (MCS) with induced by...

10.1136/ejhpharm-2016-000875.181 article EN Clinical pharmacy 2016-02-14

<h3>Background</h3> Drug shortages are caused by many factors, therefore medicines errors reported. It is necessary to know how much health quality a concern of clinical practice and patient safety involved. <h3>Purpose</h3> To check out the drug supply problems; analyse characteristics assess their impact on medium-sized hospital. <h3>Material methods</h3> A retrospective study issues was conducted from September 2012 2014. Variables analysed: type drug, expected duration shortage...

10.1136/ejhpharm-2015-000639.365 article EN 2015-03-01

<h3>Background</h3> The use of empiric antibiotics more selective than broad-spectrum is very frequent, which entails increased resistance in our environment. <h3>Purpose</h3> To evaluate the daptomycin patients with suspected infection complicated skin and soft-tissue infections (IPPBc), infectious endocarditis (EID) by meticilin resistant staphylococcus aureus (MRSA) or bacteremia MRSA associated EID IPPBc. <h3>Material methods</h3> Prospective longitudinal intervention study. We collected...

10.1136/ejhpharm-2019-eahpconf.212 article EN Section 4: Clinical pharmacy services 2019-03-01

<h3>Background and importance</h3> Drug shortages (DS) are a current global health issue facing pharmacists, prescribers patients. To deal with DS, pharmacists forced to resort different suppliers manufacturers, or seek supplies abroad, in order guarantee treatment of <h3>Aim objectives</h3> analyse DS that affected second level hospital over 1 year (March 2018 March 2019) describe measures taken by the pharmacist them. <h3>Material methods</h3> This was descriptive, observational,...

10.1136/ejhpharm-2020-eahpconf.45 article EN 2020-03-01

<h3>Background and importance</h3> Dosing optimisation means therapeutic benefit with the lowest possible dose for each patient, improving patient adherence reducing adverse effects. <h3>Aim objectives</h3> To determine impact of an implantation tool in electronic medical history (ECHR) rheumatology patients being treated biologic drugs or without optimisation. <h3>Material methods</h3> The multidisciplinary team defined strategies based on reduction dosing interval. was designed to be...

10.1136/ejhpharm-2020-eahpconf.208 article EN Section 4: Clinical pharmacy services 2020-03-01

<h3>Background and importance</h3> Clinical practice guidelines recommend oseltamivir in hospitalised patients with influenza but its use clinical is limited. <h3>Aim objectives</h3> To determine the criteria for of to analyse prescription concomitant antibiotics. <h3>Material methods</h3> An observational, descriptive, retrospective study was conducted treated (November 2018–February 2019) a second level hospital. Electronic medical history used as source information. Variables collected:...

10.1136/ejhpharm-2020-eahpconf.159 article EN Section 4: Clinical pharmacy services 2020-03-01

<h3>Background and importance</h3> Selective cyclin dependent kinase (CDK) inhibitors, palbociclib ribociclib, were recently approved to treat advanced or metastatic breast cancer. The hospital pharmacist plays an important role in the revision of treatment at consultation, order ensure safety effectiveness treatment. <h3>Aim objectives</h3> To analyse potential drug interactions (PDI) before starting ribociclib evaluate physician acceptance recommendations. <h3>Material methods</h3> This...

10.1136/ejhpharm-2020-eahpconf.175 article EN Section 4: Clinical pharmacy services 2020-03-01

<h3>Background and importance</h3> Medication errors (ME) are especially frequent in hospital emergency departments (ED). To minimise these ME, medication reconciliation programmes established, which analyse resolve the discrepancies detected regimen of patient. <h3>Aim objectives</h3> evaluate implementation programme ED a second level general hospital. <h3>Material methods</h3> An observational retrospective study was conducted. Records from patients admitted to observation area 1 January...

10.1136/ejhpharm-2021-eahpconf.335 article EN Section 5: Patient safety and quality assurance 2021-03-01
Coming Soon ...